Melanie Neary is a senior associate in the San Francisco office of Gibson, Dunn & Crutcher , where she practices in the firm’s Corporate Transactions Practice Group, with a practice focused on advising clients in connection with a variety of financing transactions, including initial public offerings, secondary equity offerings and venture and growth equity financings as well as complex corporate transactions, including mergers and acquisitions. Melanie also regularly advises clients on corporate law matters, Securities and Exchange Commission reporting requirements and ownership filings and corporate governance.

Selected Experience

• Initial Public Offerings: Apogee Therapeutics, Rain Oncology, Shattuck Labs, Biora Therapeutics, 89bio, Cricut, StepStone Group, Petco Health and Wellness Company, Odonate Therapeutics, Excelerate Energy
• Follow-on Equity Offerings: Biora Therapeutics, Viridian Therapeutics, Protagonist Therapeutics, Ultragenyx Pharmaceutical, 89bio, Odonate Therapeutics, Rain Oncology, Rockwell Medical, Heron Therapeutics, Rocket Pharmaceuticals, StepStone Group, Leslie’s, Peloton, Eledon Pharmaceuticals
• ATM Facilities: Protagonist Therapeutics, Shattuck Labs, Rain Oncology, Biora Therapeutics, Ultragenyx, Viridian Therapeutics, 89bio, Rockwell Medical, California Water Service Group, Urovant
• Debt Offerings: Mauser Packaging, California Water Service Group, Wells Fargo & Company and Wells Fargo Bank, N.A., Gran Tierra Energy, Keysight Technologies, Magnite
• Venture Financings: Apogee Therapeutics – Series B, Cullgen – Series C, Perceive Biotherapeutics – Series B, Ellodi Pharmaceuticals – Series B, Tourmaline Bio – Series A, Jaanuu – Series B, Waterloo Sparkling Water – Series D, Bandier – Series E, ConnectRN – Series F
• Mergers and Acquisitions:
• • Quidel in its acquisition of Ortho Clinical Diagnostics
  • Glassdoor in its sale to Recruit Holdings
  • BPGBio in its investment in Berg, LLC
  • California Water Service Group in Proposed Acquisition of SJW Group
  • Novus Therapeutics in merger transaction with Tokai Pharmaceuticals
  • Rocket Pharmaceuticals in merger transaction with Inotek

Melanie received her J.D. from the University of Michigan Law School in 2016, where she was the Managing Editor of the Michigan Business & Entrepreneurial Law Review. She earned her B.A., magna cum laude, in Communications, Legal Institutions, Economics and Government, with a minor in French, from American University in 2013.

Melanie is admitted to practice law in the State of California.